Literature DB >> 22976500

Preoperative FDG PET/CT in breast cancer patients: where are we going?

Laura Gilardi, Concetta De Cicco, Giovanni Paganelli.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22976500     DOI： 10.1007/s00259-012-2245-2

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  31 in total

1.  The yield of 18F-FDG PET/CT in patients with clinical stage IIA, IIB, or IIIA breast cancer: a prospective study.

Authors:  David Groheux; Sylvie Giacchetti; Marc Espié; Laetitia Vercellino; Anne-Sophie Hamy; Marc Delord; Nathalie Berenger; Marie-Elisabeth Toubert; Jean-Louis Misset; Elif Hindié
Journal:  J Nucl Med       Date:  2011-08-30       Impact factor: 10.057

2.  Glucose metabolism of breast cancer assessed by 18F-FDG PET: histologic and immunohistochemical tissue analysis.

Authors:  N Avril; M Menzel; J Dose; M Schelling; W Weber; F Jänicke; W Nathrath; M Schwaiger
Journal:  J Nucl Med       Date:  2001-01       Impact factor: 10.057

3.  Screening for metastatic disease in newly diagnosed breast cancer patients. What is cost-effective?

Authors:  J Norum; T Andreassen
Journal:  Anticancer Res       Date:  2000 May-Jun       Impact factor: 2.480

4.  Clinical significance of incidental finding of focal activity in the breast at 18F-FDG PET/CT.

Authors:  Bong Joo Kang; Ji Hye Lee; Ie Ryung Yoo; Sung Hun Kim; Jae Jeong Choi; Seung Hee Jeong; Hyeon Woo Yim
Journal:  AJR Am J Roentgenol       Date:  2011-08       Impact factor: 3.959

5.  A comparative study on the value of FDG-PET and sentinel node biopsy to identify occult axillary metastases.

Authors:  U Veronesi; C De Cicco; V E Galimberti; J R Fernandez; N Rotmensz; G Viale; G Spano; A Luini; M Intra; P Veronesi; A Berrettini; G Paganelli
Journal:  Ann Oncol       Date:  2006-12-12       Impact factor: 32.976

6.  Increased FDG uptake in breast cancer is associated with prognostic factors.

Authors:  Yasemin Sanli; Serkan Kuyumcu; Zeynep Gozde Ozkan; Göknur Işik; Hasan Karanlik; Burcu Guzelbey; Cuneyt Turkmen; Sevda Ozel; Ekrem Yavuz; Ayse Mudun
Journal:  Ann Nucl Med       Date:  2012-02-24       Impact factor: 2.668

7.  Preoperative PET/CT in early-stage breast cancer.

Authors:  M Bernsdorf; A K Berthelsen; V T Wielenga; N Kroman; D Teilum; T Binderup; U B Tange; M Andersson; A Kjær; A Loft; J Graff
Journal:  Ann Oncol       Date:  2012-02-21       Impact factor: 32.976

8.  Comparison between positron emission tomography using 2-[fluorine-18]fluoro-2-deoxy-D-glucose, conventional imaging and computed tomography for staging of breast cancer.

Authors:  S Mahner; S Schirrmacher; W Brenner; L Jenicke; C R Habermann; N Avril; J Dose-Schwarz
Journal:  Ann Oncol       Date:  2008-03-19       Impact factor: 32.976

9.  Supervised risk predictor of breast cancer based on intrinsic subtypes.

Authors:  Joel S Parker; Michael Mullins; Maggie C U Cheang; Samuel Leung; David Voduc; Tammi Vickery; Sherri Davies; Christiane Fauron; Xiaping He; Zhiyuan Hu; John F Quackenbush; Inge J Stijleman; Juan Palazzo; J S Marron; Andrew B Nobel; Elaine Mardis; Torsten O Nielsen; Matthew J Ellis; Charles M Perou; Philip S Bernard
Journal:  J Clin Oncol       Date:  2009-02-09       Impact factor: 44.544

10.  Preoperative evaluation of prognosis in breast cancer patients by [(18)F]2-Deoxy-2-fluoro-D-glucose-positron emission tomography.

Authors:  Tomoo Inoue; Kenji Yutani; Tetsuya Taguchi; Yasuhiro Tamaki; Eiichi Shiba; Shinzaburo Noguchi
Journal:  J Cancer Res Clin Oncol       Date:  2004-02-24       Impact factor: 4.553
View more
  2 in total

1.  Staging the axilla in breast cancer patients with ¹⁸F-FDG PET: how small are the metastases that we can detect with new generation clinical PET systems?

Authors:  Dimitri Bellevre; Cécile Blanc Fournier; Odile Switsers; Audrey Emmanuelle Dugué; Christelle Levy; Djelila Allouache; Cédric Desmonts; Hubert Crouet; Jean-Marc Guilloit; Jean-Michel Grellard; Nicolas Aide
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-02-22       Impact factor: 9.236

2.  The preoperative maximum standardized uptake value measured by 18F-FDG PET/CT as an independent prognostic factor of overall survival in endometrial cancer patients.

Authors:  Malgorzata Walentowicz-Sadlecka; Bogdan Malkowski; Pawel Walentowicz; Pawel Sadlecki; Andrzej Marszalek; Tomasz Pietrzak; Marek Grabiec
Journal:  Biomed Res Int       Date:  2014-01-20       Impact factor: 3.411
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.